Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey

被引:143
作者
Cuspidi, C
Ambrosioni, E
Mancia, G
Pessina, AC
Trimarco, B
Zanchetti, A
机构
[1] Univ Milan, Osped Maggiore, Ctr Fisiol Clin & Ipertens, Ist Clin Med & Terapia Med, Milan, Italy
[2] Ist Auxol, Milan, Italy
[3] Univ Bologna, Policlin S Orsola, Dipartimento Med Clin & Biotecnol Applicata, Bologna, Italy
[4] Univ Milan, Med Clin, I-20122 Milan, Italy
[5] Univ Milan, Dipartimento Med Clin Prevenzionie & Biotecnol Ap, I-20122 Milan, Italy
[6] Univ Padua, Policlin, Dipartimento Med Sperimentale, Padua, Italy
[7] Univ Naples Federico II, Med Clin 1, Naples, Italy
关键词
hypertension; cardiovascular risk stratification; echocardiography; carotid ultrasonography;
D O I
10.1097/00004872-200207000-00017
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background Echocardiography and carotid ultrasonography, by providing a more accurate assessment of cardiac and vascular damage related to hypertension, may lead to a more precise stratification of the global cardiovascular risk. However, current guidelines do not recommend systematic use of ultrasound examination of heart and large arteries in evaluating the cardiovascular risk in patients with hypertension. Objective To assess the impact of echocardiography and carotid ultrasonography on global risk stratification in hypertensive patients classified as being at low or medium risk according to routine clinical work-up as suggested by current hypertension guidelines. Methods Among 8502 consecutive patients screened at 44 outpatient hypertension hospital clinics in different parts of Italy, 1074 untreated individuals with low-to-medium risk essential hypertension were identified on the basis of the diagnostic routine procedures suggested by 1999 World Health Organization/International Society of Hypertension guidelines: medical history, physical examination and clinic blood pressure measurement; routine blood chemistry and urine analysis; electrocardiogram. The extent of risk for the 1074 individuals was reassessed by adding the results of ultrasound examinations of heart and carotid arteries: left ventricular hypertrophy (defined as left ventricular mass index > 120 g/m(2) in men and > 100 g/m(2) in women), carotid intima-media thickening (defined as diffuse thickening if greater than or equal to 0.8 mm), and presence of plaque (defined as focal thickening > 1.3 mm). Results According to routine classification, 18.7% (n = 201) of the 1074 patients were considered at low risk and 81.3% (n = 873) at medium risk. A marked change in risk stratification was obtained when ultrasound markers of target-organ damage were taken into consideration: the proportion of low-risk patients decreased to 11.1%, and that of medium risk patients to 35.7%, whereas more than 50% of the patients previously classified at low-medium risk were found to be at high absolute risk. According to a multivariate analysis, age, grade of hypertension, male sex, and serum cholesterol concentration were the variables with the greatest impact on risk class change. Conclusions Ultrasound assessment of the heart and carotid wall helps to obtain a more valid assessment of global cardiovascular risk in hypertensive patients without evidence of target-organ damage after routine examination. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:1307 / 1314
页数:8
相关论文
共 29 条
  • [1] Can echocardiography identify mildly hypertensive patients at high risk, left untreated based on current guidelines?
    Abergel, E
    Chatellier, G
    Battaglia, G
    Menard, J
    [J]. JOURNAL OF HYPERTENSION, 1999, 17 (06) : 817 - 824
  • [2] ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study
    AgabitiRosei, E
    Ambrosioni, E
    DalPalu, C
    Muiesan, ML
    Zanchetti, A
    [J]. JOURNAL OF HYPERTENSION, 1995, 13 (11) : 1325 - 1334
  • [3] [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
  • [4] VALUE OF ECHOCARDIOGRAPHIC MEASUREMENT OF LEFT-VENTRICULAR MASS IN PREDICTING CARDIOVASCULAR MORBID EVENTS IN HYPERTENSIVE MEN
    CASALE, PN
    DEVEREUX, RB
    MILNER, M
    ZULLO, G
    HARSHFIELD, GA
    PICKERING, TG
    LARAGH, JH
    [J]. ANNALS OF INTERNAL MEDICINE, 1986, 105 (02) : 173 - 178
  • [5] Chalmers J, 1999, J HYPERTENS, V17, P151
  • [6] Cardiovascular risk stratification in hypertensive patients: Impact of echocardiography and carotid ultrasonography
    Cuspidi, C
    Lonati, L
    Macca, G
    Sampieri, L
    Fusi, V
    Severgnini, B
    Salerno, M
    Michev, I
    Rocanova, JI
    Leonetti, G
    Zanchetti, A
    [J]. JOURNAL OF HYPERTENSION, 2001, 19 (03) : 375 - 380
  • [7] Prevalence of left ventricular hypertrophy and carotid thickening in a large selected hypertensive population: Impact of different echocardiographic and ultrasonographic diagnostic criteria
    Cuspidi, C
    Lonati, L
    Macca, G
    Sampieri, L
    Fusi, V
    Michev, I
    Severgnini, B
    Salerno, M
    Magrini, F
    Zanchetti, A
    [J]. BLOOD PRESSURE, 2001, 10 (03) : 142 - 149
  • [8] ELECTROCARDIOGRAPHIC DETECTION OF LEFT-VENTRICULAR HYPERTROPHY USING ECHOCARDIOGRAPHIC DETERMINATION OF LEFT-VENTRICULAR MASS AS THE REFERENCE-STANDARD - COMPARISON OF STANDARD CRITERIA, COMPUTER-DIAGNOSIS AND PHYSICIAN INTERPRETATION
    DEVEREUX, RB
    CASALE, PN
    EISENBERG, RR
    MILLER, DH
    KLIGFIELD, P
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 3 (01) : 82 - 87
  • [9] ROLE OF PRECLINICAL CARDIOVASCULAR-DISEASE IN THE EVOLUTION FROM RISK FACTOR EXPOSURE TO DEVELOPMENT OF MORBID EVENTS
    DEVEREUX, RB
    ALDERMAN, MH
    [J]. CIRCULATION, 1993, 88 (04) : 1444 - 1455
  • [10] Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension -: The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) trial
    Devereux, RB
    Palmieri, V
    Sharpe, N
    De Quattro, V
    Bella, JN
    de Simone, G
    Walker, JF
    Hahn, RT
    Dahlöf, B
    [J]. CIRCULATION, 2001, 104 (11) : 1248 - 1254